Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organogenesis Holdings (ORGO) Change in Accured Expenses: 2016-2024

Historic Change in Accured Expenses for Organogenesis Holdings (ORGO) over the last 9 years, with Dec 2024 value amounting to $9.2 million.

  • Organogenesis Holdings' Change in Accured Expenses rose 623.82% to $11.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.3 million, marking a year-over-year increase of 59.22%. This contributed to the annual value of $9.2 million for FY2024, which is 192.03% up from last year.
  • Per Organogenesis Holdings' latest filing, its Change in Accured Expenses stood at $9.2 million for FY2024, which was up 192.03% from $3.1 million recorded in FY2023.
  • In the past 5 years, Organogenesis Holdings' Change in Accured Expenses registered a high of $9.4 million during FY2021, and its lowest value of -$11.8 million during FY2022.
  • Over the past 3 years, Organogenesis Holdings' median Change in Accured Expenses value was $3.1 million (recorded in 2023), while the average stood at $150,667.
  • Per our database at Business Quant, Organogenesis Holdings' Change in Accured Expenses spiked by 548.23% in 2021 and then crashed by 226.68% in 2022.
  • Yearly analysis of 5 years shows Organogenesis Holdings' Change in Accured Expenses stood at $1.4 million in 2020, then surged by 548.23% to $9.4 million in 2021, then crashed by 226.68% to -$11.8 million in 2022, then soared by 126.48% to $3.1 million in 2023, then spiked by 192.03% to $9.2 million in 2024.